feed,title,long_url,short_url
Investors,"Kymera Rockets, Pulling Nurix Higher. Does It Have The Next Dupixent?",https://www.investors.com/news/technology/kymera-therapeutics-nurix-therapeutics-stat6-degrader-dupixent/,
Investors,Marvell Stock Down As Microsoft Mulls Switch To Broadcom For Custom Chips,https://www.investors.com/news/technology/marvell-stock-microsoft-mulls-switch-to-broadcom/,
Investors,Structure Therapeutics Soars; CEO Says It Could Have 'Best-In-Class' Weight-Loss Drug,https://www.investors.com/news/technology/structure-therapeutics-stock-weight-loss-drug/,
